The impact of the number of CD34+ cells infused on the hematologic recovery after autologous peripheral blood stem cell (PBSC) transplantation.

被引：0
|
作者：
Palomera, L
Azaceta, G
Varo, MJ
Moreno, JA
Olave, T
Domingo, JM
Mayordomo, JI
Gutiérrez, M
机构：
[1] Clin Hosp, Dept Hematol, Zaragoza, Spain
[2] Clin Hosp, Dept Oncol, Zaragoza, Spain
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4310
引用
收藏
页码：304B / 304B
页数：1
相关论文
共 50 条
  • [1] The impact of the number of CD34+ cells infused on engraftment in autologous blood stem cell transplantation (ABSCT)
    Azaceta, G
    Palomera, L
    Mayordomo, JI
    Alonso, M
    Moreno, JA
    Domingo, JM
    Varo, MJ
    Tres, A
    Fuertes, MA
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 204 - 204
  • [2] Impact of the number of cryopreserved CD34+ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study
    Partanen, Anu
    Turunen, Antti
    Silvennoinen, Raija
    Valtola, Jaakko
    Pyorala, Marja
    Siitonen, Timo
    Sikio, Anu
    Putkonen, Mervi
    Sankelo, Marja
    Penttila, Karri
    Kuittinen, Taru
    Mantymaa, Pentti
    Pelkonen, Jukka
    Jantunen, Esa
    Varmavuo, Ville
    JOURNAL OF CLINICAL APHERESIS, 2023, 38 (01) : 33 - 44
  • [3] Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy
    Bensinger, WI
    Buckner, CD
    Rowley, S
    Demirer, T
    Storb, R
    Appelbaum, FA
    BONE MARROW TRANSPLANTATION, 1996, 17 : S38 - S39
  • [4] Loss of CD34+ Cells and Effect of the Number of Viable Cryopreserved CD34+ Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation
    Partanen, Anu
    Turunen, Antti
    Valtola, Jaakko
    Pyorala, Marja
    Kuittinen, Outi
    Kuitunen, Hanne
    Vasala, Kaija
    Penttila, Karri
    Kuittinen, Taru
    Mantymaa, Pentti
    Pelkonen, Jukka
    Jantunen, Esa
    Varmavuo, Ville
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11): : E428 - E435
  • [5] Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in older patients with advanced hematologic malignancy
    Schiller, G
    Rowley, S
    Buckner, CD
    Berenson, R
    Benyunes, M
    Appelbaum, FR
    Bensinger, WI
    BLOOD, 1995, 86 (10) : 1545 - 1545
  • [6] Infused CD34+/CD90+ cell number is more effective than CD34+/AC133+cells to predict late hematopoietic reconstitution following autologous peripheral blood stem cell transplantation.
    Shimazaki, C
    Sumikuma, T
    Inaba, T
    Ochiai, N
    Okano, A
    Hatsuse, M
    Ashihara, E
    Nakagawa, M
    BLOOD, 2001, 98 (11) : 321B - 321B
  • [7] Short immunological reconstitution after autologous unselected and selected CD34+ peripheral blood stem cell transplantation.
    Laurenti, L
    Sica, S
    Sorà, F
    Cicconi, S
    Chiusolo, P
    Piccirillo, N
    La Barbera, EO
    Rumi, C
    Menichella, G
    Leone, G
    BONE MARROW TRANSPLANTATION, 1999, 23 : S230 - S230
  • [8] Use of unselected versus CD34+ selected immunoaffinity (Cellpro®) and immunomagnetic (Clinimacs®) peripheral blood stem cells (PBSC) in autologous transplantation.
    Engelhardt, M
    Jähne, A
    Lange, W
    Fetscher, S
    Mertelsmann, R
    BLOOD, 1998, 92 (10) : 442A - 442A
  • [9] CD34+/CD41+ cells best predict platelet recovery after autologous peripheral blood stem cell transplantation
    Feng, R
    Shimazaki, C
    Inaba, T
    Takahashi, R
    Hirai, H
    Kikuta, T
    Sumikuma, T
    Yamagata, N
    Ashihara, E
    Fujita, N
    Nakagawa, M
    BONE MARROW TRANSPLANTATION, 1998, 21 (12) : 1217 - 1222
  • [10] CD34+/CD41a+ cells best predict platelet recovery after autologous peripheral blood stem cell transplantation
    R Feng
    C Shimazaki
    T Inaba
    R Takahashi
    H Hirai
    T Kikuta
    T Sumikuma
    N Yamagata
    E Ashihara
    N Fujita
    M Nakagawa
    Bone Marrow Transplantation, 1998, 21 : 1217 - 1222
12345